Resistance to Molecular Therapies for Hepatocellular Carcinoma (Hardcover, 1st ed. 2017)

This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Resistance to Targeted Anti-Cancer Therapeutics, 13
Release date:	July 2017
First published:	2017
Editors:	Augusto Villanueva
Dimensions:	235 x 155mm (L x W)
Format:	Hardcover
Pages:	147
Edition:	1st ed. 2017
ISBN-13:	978-3-319-56196-7
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	3-319-56196-0
Barcode:	9783319561967

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!